Merck and Japan's Eisai said on Wednesday they will shut down a late-stage study testing an experimental combination therapy ...

Liver cancer screening uses ultrasound and AFP biomarker tests, with CT or MRI for further evaluation if abnormalities are ...

Merck and Eisai halt late-stage trial as Keytruda/Lenvima combo fails to improve survival in liver cancer. Read more here.

Patients enrolled had NET liver metastases of any grade or origin that were progressive, symptomatic, or represented a high ...

A Shropshire woman with a deadly cancer has been fundraising for life-extending treatment through bake sales. NHS worker ...

After a progression-free survival win last year raised hopes for the combo's potential in hepatocellular carcinoma, an overall survival miss brings the study to a close.

A cancer patient who works at the NHS is trying to raise £120,000 for chemotherapy after she was refused the treatment. Jamie ...

MSD, known as Merck & Co in the US and Canada, licensed rights to Lenvima in 2018 in a near-$6 billion deal aimed at developing it as a partner drug to Keytruda. The combination has been approved for ...

A TIKTOKER battling cancer paid a heartbreaking tribute to her husband and spoke about her future plans in a post shared ...

As the incidence of obesity continues to rise nationally and globally, a new observational study published in Cancer reports ...

A healthy diet can turn things around faster than you can imagine. Dr. Dawn Mussallem, who appeared on Mel Robbins’ podcast, ...

Here’s what one woman wants others to know about moving forward with strength and hope after an early breast cancer diagnosis ...